Arm's AI-Driven CPU Thesis Gains Momentum, But Execution Hurdles Persist

What happened

A new article highlights that Agentic AI is shifting compute bottlenecks toward CPUs, increasing demand for orchestration-heavy workloads where Arm's architecture becomes more central in hyperscaler systems. It points to Arm's 27% royalty growth to $737 million and 21 CSS licenses as evidence of a successful transition from volume-focused licensing to a value-extraction platform. However, the DeepValue master report cautions that Arm's stock, at $125.28, trades at extreme valuations with a P/E of 166x and EV/EBITDA of 145x, leaving no margin for error. Key risks include a forecasted 2.1% decline in smartphone shipments, which accounts for 46% of royalties, and high customer concentration that could disrupt growth. Despite the positive narrative, the report maintains a 'WAIT' rating, requiring proof in the next two quarters that ACV growth sustains and royalties remain resilient.

Implication

The article reinforces Arm's strategic shift to higher-value products, but investors must recognize that current prices already embed optimistic growth assumptions with little room for error. High multiples amplify downside risk if royalty growth falters or licensing momentum wanes, as seen in past post-earnings volatility driven by 'license optics.' Smartphone unit declines and export control challenges in China threaten to undermine the mix shift, making sustained royalty growth uncertain. Monitoring upcoming quarterly results for ACV trends and RPO stabilization is critical to assess forward visibility and validate the narrative. Until these risks are mitigated, a patient approach aligns with the DeepValue report's 'WAIT' rating and limited margin of safety.

Thesis delta

The new article adds incremental support for Arm's bull case by emphasizing AI-driven CPU demand and CSS adoption, which aligns with the report's upside scenario. However, it does not shift the core thesis, as the fundamental concerns—overvaluation, smartphone cyclicality, and customer concentration—remain unchanged and unaddressed by the article's promotional tone. Thus, the investment call stays at 'WAIT,' pending concrete evidence from the next quarters that ACV and royalty growth can defy headwinds.